LOGC - LogicBio Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development11,0793,5582,030
Selling General and Administrative6,8642,2961,373
Non Recurring---
Total Operating Expenses17,9435,8543,403
Operating Income or Loss-17,943-5,854-3,403
Income from Continuing Operations
Total Other Income/Expenses Net408121-7
Earnings Before Interest and Taxes-17,943-5,854-3,403
Interest Expense---1
Income Before Tax-17,535-5,733-3,410
Income Tax Expense866218
Minority Interest---
Net Income From Continuing Ops-17,621-5,795-3,428
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-17,621-5,795-3,428
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-17,621-7,735-3,765